The clinical benefits of rehabilitation in cardiovascular disease are well established. Among cardiovascular disease patients, however, patients with type 2 diabetes mellitus require a distinct approach. Specific challenges to clinicians and healthcare professionals in patients with type 2 diabetes include the prevalence of peripheral and autonomic neuropathy, retinopathy, nephropathy, but also the intake of glucose-lowering medication. In addition, the psychosocial wellbeing, driving ability and/or occupational status can be affected by type 2 diabetes. As a result, the target parameters of cardiovascular rehabilitation and the characteristics of the cardiovascular rehabilitation programme in patients with type 2 diabetes often require significant reconsideration and a multidisciplinary approach. This review explains how to deal with diabetes-associated comorbidities in the intake screening of patients with type 2 diabetes entering a cardiovascular rehabilitation programme. Furthermore, we discuss diabetes-specific target parameters and characteristics of cardiovascular rehabilitation programmes for patients with type 2 diabetes in a multidisciplinary context, including the implementation of guideline-directed medical therapy.
Introduction
Structured rehabilitation programmes are an integral part of care for patients with a cardiovascular event. They facilitate the restoration of the patients' functional capacity, improve the quality of life, enable optimal re-integration into daily life and reduce the risk of having a subsequent cardiovascular event or experiencing hospitalisations. 1, 2 The components of such a cardiovascular rehabilitation programme encompass the implementation of guideline-directed medical therapies, psychological support or counselling, the facilitation of (early) return to work and reconsideration of driving ability, as well as lifestyle measures such as smoking cessation, dietary adjustments and physical activity. The latter includes specific exercise programmes and the integration of sufficient physical activity into the daily life.
A large proportion of patients who recover from a cardiovascular event, however, also have diabetes mellitus (e.g. in AE 30% of patients recovering from an acute myocardial infarction), 3 which affects the content of a cardiovascular rehabilitation programme. For example, typical diabetes-related comorbidities and/or the intake of glucose-lowering medication may hamper the direct translation of physical activity recommendations from non-diabetic to diabetic cardiovascular disease (CVD) patients. In addition, specific dietary measures and additional psychosocial support may be indicated in patients with type 2 diabetes mellitus (T2DM). As a result, adjusting and personalising a rehabilitation programme to CVD patients with T2DM may be challenging for clinicians.
This paper summarises the current state of the art rehabilitation for CVD patients with T2DM and addresses key differences compared to CVD patients without diabetes. First, the intake screening will be described in greater detail, followed by what to target as well as a detailed description of the components of a rehabilitation programme for CVD patients with T2DM.
Intake screening in CVD patients with T2DM
The optimisation of rehabilitation in CVD patients with co-existent T2DM starts with a proper intake screening, in which the glycaemic control, comorbidities and functional status are key elements.
Assessment of glycaemic control
The diagnosis of T2DM is established when either the fasting plasma glucose concentration is 125 mg/dL or greater (7.0 mmol/L), 2-hour plasma glucose concentration during a 75 g oral glucose tolerance test is 200 mg/dL or greater (11.1 mmol/L), or haemoglobin A1c (HbA1c) is 6.5% or greater (48 mmol/mol). 4, 5 However, for feasibility reasons clinicians mostly rely on fasting blood glucose concentrations and/or capillary blood glucose measurements, as regular follow-up is warranted in these individuals. Optimal fasting blood glucose concentrations then typically range between 80 and 120 mg/dl (4.4-6.7 mmol/l) and postprandial concentrations should not exceed 180 mg/dl (10.0 mmol/l). However, older patients could experience hypoglycaemia more frequently in response to blood glucoselowering therapies. 5 Therefore, in these patients, and without established micro and macrovascular complications, higher blood glucose concentrations are acceptable.
Investigation of comorbidities
Diabetes end-organ assessment. At entry to rehabilitation, the presence of microvascular complications should be assessed in T2DM patients (Table 1) . Such comorbidity is clearly associated with an elevated risk of cardiovascular events, may require specific treatment, or represents a contraindication to some antidiabetic medications or types of exercise/physical activity. As a result of the potential presence of microvascular disease, retinal complications such as maculopathy or proliferative retinopathy should be ruled out. Systemic microvascular deterioration might also lead to peripheral and/or autonomic neuropathy, as well as nephropathy. Simple clinical tests are available to rule out peripheral neuropathy and/or autonomic neuropathy. Autonomic neuropathy can also be verified by cardiopulmonary exercise testing (CPET), in which altered heart rate (HR) changes are most apparent, such as chronotropic incompetence and slowed HR recovery. Chronotropic incompetency is associated with exercise intolerance and increased risk of major cardiovascular events and premature death. 6, 7 In patients with T2DM, HR recovery is an independent predictor of reduced exercise capacity, CVD and all-cause mortality. 7-10 To assess renal function or rule out nephropathy, clinicians are advised to execute routine blood and/or urine sample analyses.
To assess/examine the presence of macrovascular complications, the peripheral vascular status of the lower extremities and ECG during exercise testing should be evaluated closely. Special attention should be paid to silent myocardial ischaemia during CPET (may be present in one of five T2DM patients). 11, 12 In diabetes mellitus, equivocal and abnormal exercise ECG responses are associated with a higher risk of all-cause, CVD and coronary artery disease mortality. 13 In patients with chest pain (present in AE 16% of T2DM patients), CPET shows a better diagnostic and predictive accuracy than traditional ECG stress testing to detect myocardial ischaemia. 14 An echocardiogram should be performed to rule out myocardial dysfunction.
The orthopaedic system should be examined for specific symptoms and/or movement limitations, and the clinician should be aware of increased hip fracture risk. 15 The feet deserve great attention for dermatological and musculoskeletal risk factors. The diabetic foot may be defined as a group of syndromes in which neuropathy, ischaemia and infection lead to tissue breakdown, resulting in morbidity and possible amputation. 16 Unhealthy diet and nutritional comorbidities. Unhealthy eating patterns can cause a significant excess mortality primarily due to a deficiency in legume, vegetable, fibre and unsaturated fatty acid intake and excessive intake of salt, sugar sweetened beverages, saturated fat and processed meat. 17, 18 Food intake determines blood glucose concentrations, in which the intake of carbohydrates is of particular importance to T2DM patients. Therefore, the assessment of nutrition and diet is important in T2DM patients.
Moreover, malnutrition, sarcopenia, or obesity with sarcopenia, is frequently present in older and frail patients, while obesity is highly prevalent in T2DM patients. Sarcopenia, which is in essence the combination of muscle weakness and low muscle mass, should thus be ruled out. Nutritional deficiencies are frequent in older people for various reasons and vitamin D deficiency is present in over 50% of the elderly. Blood vitamin B12 may be lowered due to metformin therapy or low meat intake and may contribute to peripheral and autonomic neuropathy. Therefore, the assessment of blood vitamin D and B12 concentrations may be relevant in subgroups of T2DM patients.
Psychosocial comorbidities. People with T2DM more often struggle with psychosocial difficulties, leading to a diminished psychological wellbeing. 19, 20 Strained coping with life routines change, concerns about hypoglycaemia and diabetes complications, and low social support can elicit psychosocial difficulties. 19, 21, 22 Compared with healthy persons, clinical depression and anxiety therefore occur twice as often in patients with diabetes. 23 Moreover, social support, especially family support, can be a vital component in the successful control of diabetes, and is related to a better quality of life. 24 For all these reasons, all individuals with T2DM need to have a psychosocial evaluation at entry to rehabilitation. 25 Sleep apnoea syndrome. Approximately 50-90% of all T2DM patients have obstructive sleep apnoea (OSA) syndrome, which is diagnosed when the apnoeahypopnoea index equals or exceeds 15 events/hour, or between 5 and 15 events/hour with excessive daytime sleepiness, or laboured breathing during the apnoea event. 26 OSA can lead to insomnia and is highly unfavourable as it elicits hypertension, increased activity of the sympathetic nervous system and systemic insulin resistance that can exacerbate the pathophysiology of T2DM. 26 Therefore, OSA should be ruled out or treated when detected.
After this intake screening, the clinician should be aware of conditions that can have a significant impact on the content of the rehabilitation programme (e.g. feasibility and medical safety). By a further assessment of the functional status, however, the clinician also obtains objective and modifiable targets for rehabilitation.
Functional status
Risk factors. As most patients with T2DM are overweight/obese and such a clinical state relates to prognosis, the determination of the waist circumference or fat mass is crucial. The waist circumference must be assessed midway between the lowest rib and the iliac crest. 27 In European men and women, a waist circumference of less than 94 cm and less than 80 cm, respectively, is considered normal. Bio-impedance analysis is a simple and clinically useful tool to assess body composition (in particular fat mass) but needs appropriate software and interpretation. 28 The prevalence of hypertension in patients who have T2DM (defined as a blood pressure (BP) > 140/ 90 mmHg) is up to three times higher than in patients without diabetes, 29 and is a strong independent risk factor for CVD and chronic kidney disease. A strict follow-up of the BP in the setting of T2DM is therefore recommended. 5, 30 In this regard, the ambulatory and/or home-based BP should be assessed, as this may identify masked hypertension. 30 Hypertension during the sleep may also be suggestive of OSA. Moreover, the BP response during exercise should also always be assessed, as apparently normotensive T2DM patients still can experience a hypertensive response during physical exertion. 31 Blood lipid profile abnormalities are highly common in T2DM patients, and are particularly characterised by elevations in blood low-density lipoprotein (LDL) cholesterol concentrations. As a result, blood LDLcholesterol should be evaluated. 5 Physical activity. A sedentary lifestyle and reduced exercise capacity are common features in T2DM and are associated with a worse prognosis. 32, 33 The assessment of physical activity is therefore clinically relevant. Physical activity can be estimated by questionnaires, motion sensors, accelerometers or pedometers. 34 Selfreport instruments are the most widely used tools to assess physical activity, despite limitations such as reliability in self-assessment, difficulties in ascertaining the frequency, duration and intensity of physical activity, social desirability bias and the cognitive demands of recall. 34 The international physical activity questionnaire seems, however, to be adequate for clinical assessment in patients with T2DM. 35 Step counters may further help to assess physical activity objectively in patients with T2DM and can easily be employed using modern smartphones (5000-10,000 daily steps: insufficiently active, < 5000 daily steps: inactive). 36 Exercise capacity. CPET is the gold standard to quantify accurately cardiorespiratory fitness, identify exerciselimiting pathophysiological mechanisms, formulate function-based prognostic stratification and determine exercise training zones based on ventilatory thresholds. 37 In T2DM patients, a reduced cardiorespiratory fitness is usually associated with subclinical left ventricular dysfunction, insulin resistance and a poor glycaemic control. 38 A peak oxygen uptake of less than 75% of the normal value is considered as significantly reduced, in which the aetiology for such deconditioning should be explored. 39 After completion of this part of the intake screening, clinicians can define the personalised goals of the rehabilitation programme.
What to target and how to intervene in CVD patients with diabetes Glycaemic control
A HbA1c target for most adults with T2DM is less than 7.0% (<53 mmol/mol). 5 However, more stringent HbA1c goals of less than 6.5% (48 mmol/mol) may be suggested on a personalised basis if this can be achieved without significant hypoglycaemia or other adverse effects of treatment. Less stringent HbA1c goals of less than 8.0% (64 mmol/mol) or less than 9.0% (75 mmol/mol) may be adequate for the elderly.
Physical activity and exercise training
Increasing the daily physical activity level is crucial in the treatment of patients with CVD and T2DM, as it leads to improved physical fitness, muscle strength, glycaemic control (reductions in HbA1c by approximately 0.7%), vascular function and inflammation (Table 2) . Moreover, exercise training increases the effect of pharmacological or dietary strategies for lowering BP, blood LDL-cholesterol and fat mass. 40 Although the largest trial evaluating the effect of a combined exercise and weight loss intervention in T2DM patients failed to show a decline in cardiovascular events in the long term, this is mainly due to non-adherence to lifestyle and medication prescriptions. 41 Therefore, future strategies to improve physical activity and physical fitness in patients with diabetes and CVD should not only consist of structured supervised exercise training programmes. They should be combined with strategies aimed at improving long-term adherence and incorporating an active lifestyle in daily life in which patients play a more active role.
The optimal composition of exercise training programmes in CVD patients with T2DM is dependent on individual treatment targets. When targeting glycaemic control and physical fitness, the most optimal training programme should consist of at least three to five aerobic exercise training sessions of sufficient duration and intensity. [42] [43] [44] In particular, a higher exercise frequency relates to greater improvements in glycaemic control in T2DM patients. High-intensity interval training at 90-95% peak oxygen uptake might potentially be superior to moderate to intense programmes for improving glycaemic control, although the study samples sizes are small. 45 Therefore, high-intensity interval training is not yet a sufficiently established feasible and safe modality for all T2DM patients due to the high level of required motivation and disease-related barriers for performing training at high intensity (e.g. cardiac autonomic neuropathy, peripheral arterial disease, cardiac arrhythmias, (silent) myocardial ischaemia). Resistance training is effective as an adjunct to aerobic exercise training for further improving glycaemic control. 40, 46 In T2DM patients the volume of resistance training seems, however, to be the most important training modality. 47 Besides participating in structured exercise training programmes, CVD patients with T2DM should be strongly encouraged to adopt a healthy lifestyle and to increase daily physical activity levels. As such, easily implementable lifestyle changes, such as reducing sedentary time by interrupting sitting with light exercise, seem to be effective in improving glycaemic control in T2DM patients. [48] [49] [50] In addition, the introduction of new digital health-based healthcare models and innovations in telecommunication technologies provide new opportunities for T2DM patients. 51 When such exercise is planned, medical safety should also be maximised. Hypoglycaemia may form an important barrier for adherence to exercise training programmes to T2DM patients. Therefore, blood glucose monitoring (by capillary measurements) is recommended in T2DM patients during the first weeks of exercise training programmes. 52 This particularly applies to patients with a higher age, lower body mass index, impaired renal function, a history of microvascular complications, dementia, previous hypoglycaemic events, longer duration of T2DM and lower education. 53 Also caution is warranted in patients using insulin, glinides and/or sulphonylureas as hypoglycaemic events are observed more frequently in these individuals. Flow charts should be used to adjust medication dose in relation to the observed blood glucose concentrations ahead of, and during, exercise training. 54 When retinopathy and/or nephropathy is diagnosed, high-intensity exercise and/or hypertensive responses to exercise should be avoided.
Risk factor control: BP, lipids, body weight and composition
In addition to the favourable effects of exercise training and physical activity on glycaemic control in CVD patients with T2DM, such intervention also leads to reductions in blood lipids, BP and fat mass. However, the proper selection of training modalities is instrumental to improve these cardiovascular risk factors. 55 In the management of high BP, aerobic exercise training is recommended. 55 In particular, a sufficient intensity and frequency seems key to optimise BP. As an adjunct, dynamic resistance exercise can be advised. 55 As dynamic resistance exercise training might temporarily increase BP, dynamic resistance exercises at greater intensities (>70% of 1-repetition maximum) with fewer repetitions (n¼<10) actually elicits smaller increments in systolic BP and cardiac output, when compared to lower intensities (<50% of 1-repetition maximum) with more repetitions n¼>20)). 56 Furthermore, the addition of isometric strength training exerts a larger reduction in BP in hypertensive patients. 57 The impact of exercise training on the blood lipid profile differs between different patient populations. In patients with CVD, 58 reductions in blood total cholesterol and triglycerides may be expected while in patients with T2DM reductions in blood LDL-cholesterol and improvements in high-density lipoprotein (HDL) cholesterol may be anticipated. 59 However, the impact of the intake of blood lipid-lowering drugs (such as statins), but also caloric intake restriction, is of such magnitude on the blood lipid profile that it may overrule/mask the impact of exercise training. Aerobic moderate to intense exercise training, eliciting a sufficient weekly energy expenditure, is most often implemented with the aim to improve the blood lipid profile. 60 The influence of physical activity on blood lipid profile takes a while to be noticed, so prolonged exercise interventions seem to be needed to affect the blood lipid profile significantly (!12 weeks). 54 Also, (the addition of) resistance training exercises positively affect blood HDL-cholesterol concentrations as well as other lipoproteins and total cholesterol. 61 Therefore, resistance/strength training could be added to endurance training.
It is well known that exercise training only leads to marginal changes in body weight. 62 Therefore, the addition of energy intake restriction is key to maximise weight loss in patients with obesity. T2DM patients who manage to lose at least 10% of their body weight have a 20% lower risk of incident CVD, so weight loss is an important aim. 63 To reduce fat mass in obese individuals, a high energy expenditure should be strived for. 64, 65 Although resistance training should be added on top of endurance training to affect lean tissue mass, muscle strength, blood lipid profile and resting metabolic rate, such addition does not lead to greater reductions in fat mass. 66 Moreover, exercise training in the fasted state, 67 or exercise training at the maximal fat oxidation rate, 68 does not maximise fat mass reductions.
Exercise should thus be viewed as a complement to guideline-directed medical therapy. Antihypertensive and lipid-lowering therapy should be initiated and/or up-titrated during the programme to achieve diabetesspecific BP and lipid goals. 5
Psychosocial status
How to optimise the psychosocial status in CVD patients with T2DM is addressed in greater detail in another paper in this issue. 69 In T2DM patients with 86 and Landgraf et al. 87 clinical depression and/or psychosocial difficulties, access to illness-management resources and social support, psycho-education, distress management and strengthening self-efficacy may improve treatment adherence, diabetes self-management and/or quality of life. Care models that consider cultural influences, as well as personal, family and community resources are herein more likely to be successful. 70 
Sleep apnoea syndrome
In the treatment of OSA, continuous positive airway pressure during sleeping, aerobic exercise training and dietary intervention is advocated. 26 If insomnia is coexistent, the addition of certain drugs can be considered, such as c-aminobutyric-acid (GABA) A receptor modulators or orexin receptor antagonists, as well as cognitive behavioural therapy. 26 Return to work and driving ability Employment decisions can have an impact on mental health 71 and can have economic repercussions. As a result, decisions for professional reintegration should be individualised. For T2DM patients with stable glycaemic control there are only a few restrictions on occupational reintegration. In particular, the risk of hypoglycaemia and coincidental diabetes-related complications (e.g. neuropathy, retinopathy) are limiting for professional reintegration. Basically, the following aspects should be taken into account when considering occupational reintegration: endangering themselves or others, long-term quality/stability of metabolic control, type of anti-diabetic medication, characteristics of hypoglycaemia (e.g. frequency, perception, need of external assistance), current disease management and psychosocial coping with the illness. 72 In physically demanding jobs, the monitoring of blood glucose concentrations can be recommended in the first few weeks to avoid severe hypoglycaemia. However, a single episode of severe hypoglycaemia should not per se disqualify an individual from employment, but may reinforce the awareness of the safety of the individual. 73 If the medication is stable, there are no restrictions on shift, night or piece work.
The individual ability to drive is an important aspect in certain T2DM patients, and is aligned to the group of driving classes, the glucometabolic stability and the individual risk of hypoglycaemia. 74 Sudden hypoglycaemia followed by unconsciousness is the most important concern when assessing the ability to drive, whereas the tendency is more pronounced in T2DM patients treated with insulin, sulfonylureas or glinides. 75 The reader is referred to specialised literature for more details. [75] [76] [77] Nutrition While older nutritional recommendations targeted specific ranges of macronutrients, newer recommendations rather focus on dietary patterns. 5, 78 Hydrogenated and hardened fats should be avoided and saturated fats kept to a minimum. Sugar should be kept to a minimum, i.e. 25 g/day. Rapidly digestible starches in white bread, rice or pasta/noodles, cakes and cookies causing rapid and dose-dependent increases in blood glucose should be avoided, while whole grain cereals and brown rice is preferred. The quantity of carbohydrate plays an important role in postprandial glycaemia and should be limited per meal. Fruits low in sugar such as berries should be preferred to fruits rich in sugar (e.g. grapes, banana) and fruit quantity should not exceed 300 g/day. Non-starchy vegetables should be a preferred food and eaten in amounts of over 400 g/day. This will supply many micronutrients and help in weight management. Legumes (e.g. beans, peas, lentils) cause only moderate rises in blood glucose and represent healthy and nutritious foods with a high content of protein, fibre, minerals and slow carbohydrates. Healthy mono and polyunsaturated fatty acids (MUFA and PUFA) are generally under-consumed, which may contribute to excess mortality. 15, 16 The intake of seeds and nuts with a high content of PUFA and MUFA, and additionally of minerals and plant proteins is generally recommended, but in well controlled quantities, because of the high energy density. Different dietary patterns can be successfully applied to control blood glucose, such as low carbohydrate, low fat, vegan, vegetarian, protein-rich low-carbohydrate diets. In addition, a Mediterranean diet, rich in polyunsaturated and monounsaturated fats (with the inclusion of olive oil), should be considered to reduce cardiovascular events. 5 Several specific patterns such as the DASH diet, a low sodium, plant food and protein emphasising diet to reduce hypertension and many variants thereof can be successfully applied. 78, 79 Low carbohydrate diets containing 5-40% of the energy intake as carbohydrate are successful to control blood glucose rapidly. Longterm studies, however, do not observe advantages of low carbohydrate over low fat diets. [78] [79] [80] Education, self-empowerment, adherence and behavioural change
The clinical outcomes in T2DM will depend on selfmanagement: good self-care protects against diabetesrelated complications. 81 For this self-management, T2DM patients should receive education and personalised counselling. Until very recently, the health professional was the authority responsible for diagnosis and treatment, while patient education was generally prescriptive. These models are, however, not effective in diabetes care. 82 T2DM patients should be in control and responsible for the daily self-management of their condition. 83 This approach is based on three aspects of chronic illness care: 84 1. Choices -the choices that patients make each day, as well as their care for diabetes, have a greater impact on their outcomes than those made by health professionals. 2. Control -patients are in charge of their self-management behaviours. Once patients leave the medical offices, they are in control of which recommendations they should implement or ignore. 3. Consequences -because the consequences of these decisions accrue directly to patients, they have both the right and the responsibility to manage diabetes in the way that is best suited to the context and culture of their lives.
In this process, patient empowerment is important. Empowerment is a patient-centred, collaborative approach tailored to match the fundamental realities of diabetes care, in which education is a crucial component. It helps patients to discover and develop the inherent capacity to be responsible for one's own life. Approaches to education within the empowerment philosophy incorporate interactive teaching strategies designed to involve T2DM patients in problem solving and address their cultural and psychosocial needs. Personal setting within the empowerment approach 85 is a five-step process that provides patients with the information and clarity they need to develop and reach their diabetes and lifestyle-related goals (Figure 1 ).
Conclusion
In patients with CVD, T2DM is highly prevalent. Such comorbidity should trigger clinicians and healthcare providers to execute a thorough intake screening and intervene, both on lifestyle and medication, in a multidisciplinary context during cardiovascular rehabilitation.
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